{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:45:09Z","timestamp":1788273909069,"version":"build-2803163510"},"reference-count":97,"publisher":"Archives of Endocrinology and Metabolism","issue":"special issue","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,18]]},"DOI":"10.20945\/2359-4292-2024-0073","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T19:27:09Z","timestamp":1732217229000},"source":"Crossref","is-referenced-by-count":3,"title":["Modulating gene expression as a strategy to investigate thyroid cancer biology"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6405-0635","authenticated-orcid":false,"given":"Diego Claro","family":"de Mello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6399-3095","authenticated-orcid":false,"given":"Joice Moraes","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8767-4662","authenticated-orcid":false,"given":"Antonio Tarelo Freitas","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9110-5788","authenticated-orcid":false,"given":"Marcella Maringolo","family":"Cristov\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8403-4459","authenticated-orcid":false,"given":"Edna Teruko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0567-5432","authenticated-orcid":false,"given":"Cesar Seigi","family":"Fuziwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"5","key":"key20241121192703_B1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid Cancer: A Review","volume":"331","author":"Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME. Thyroid Cancer: A Review. JAMA. 2024;331(5):425-35. doi: 10.1001\/jama.2023.26348.","journal-title":"JAMA"},{"issue":"11","key":"key20241121192703_B2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMra1501993","article-title":"Biologic and Clinical Perspectives on Thyroid Cancer","volume":"375","author":"Fagin","year":"2016","unstructured":"Fagin JA, Wells SA Jr. Biologic and Clinical Perspectives on Thyroid Cancer. N Engl J Med. 2016;375(11):1054-67. doi: 10.1056\/NEJMra1501993.","journal-title":"N Engl J Med"},{"issue":"9","key":"key20241121192703_B3","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1021\/acs.chemrestox.9b00215","article-title":"Cell Lines as Biological Models: Practical Steps for More Reliable Research","volume":"32","author":"Capes-Davis","year":"2019","unstructured":"Capes-Davis A, Bairoch A, Barrett T, Burnett EC, Dirks WG, Hall EM, et al. Cell Lines as Biological Models: Practical Steps for More Reliable Research. Chem Res Toxicol. 2019;32(9):1733-6. doi: 10.1021\/acs.chemrestox.9b00215.","journal-title":"Chem Res Toxicol"},{"issue":"10","key":"key20241121192703_B4","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-18-2953","article-title":"Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies","volume":"25","author":"Landa","year":"2019","unstructured":"Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, et al. Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clin Cancer Res. 2019;25(10):3141-51. doi: 10.1158\/1078-0432.CCR-18-2953.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"key20241121192703_B5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41568-023-00598-y","article-title":"Pathogenesis of cancers derived from thyroid follicular cells","volume":"23","author":"Fagin","year":"2023","unstructured":"Fagin JA, Krishnamoorthy GP, Landa I. Pathogenesis of cancers derived from thyroid follicular cells. Nat Rev Cancer. 2023;23(9):631-50. doi: 10.1038\/s41568-023-00598-y.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"key20241121192703_B6","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1158\/0008-5472.CAN-05-0047","article-title":"Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation","volume":"65","author":"Knauf","year":"2005","unstructured":"Knauf JA, Ma X, Smith EP, Zhang L, Mitsutake N, Liao XH, et al. Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. Cancer Res. 2005;65(10):4238-45. doi: 10.1158\/0008-5472.CAN-05-0047.","journal-title":"Cancer Res"},{"issue":"28","key":"key20241121192703_B7","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/onc.2011.44","article-title":"Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGF\u03b2 signaling","volume":"30","author":"Knauf","year":"2011","unstructured":"Knauf JA, Sartor MA, Medvedovic M, Lundsmith E, Ryder M, Salzano M, et al. Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGF\u03b2 signaling. Oncogene. 2011;30(28):3153-62. doi: 10.1038\/onc.2011.44.","journal-title":"Oncogene"},{"issue":"12","key":"key20241121192703_B8","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1172\/JCI46382","article-title":"Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation","volume":"121","author":"Chakravarty","year":"2011","unstructured":"Chakravarty D, Santos E, Ryder M, Knauf JA, Liao XH, West BL, et al. Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. J Clin Invest. 2011;121(12):4700-11. doi: 10.1172\/JCI46382.","journal-title":"J Clin Invest"},{"issue":"4","key":"key20241121192703_B9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1073\/pnas.1015557108","article-title":"Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice","volume":"108","author":"Franco","year":"2011","unstructured":"Franco AT, Malaguarnera R, Refetoff S, Liao XH, Lundsmith E, Kimura S, et al. Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proc Natl Acad Sci U S A. 2011;108(4):1615-20. doi: 10.1073\/pnas.1015557108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"key20241121192703_B10","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1158\/1078-0432.CCR-19-2531","article-title":"Genetics of Human Thyroid Cancer Cell Lines-Response","volume":"25","author":"Landa","year":"2019","unstructured":"Landa I, Pozdeyev N, Knauf JA, Haugen BR, Fagin JA, Schweppe RE. Genetics of Human Thyroid Cancer Cell Lines-Response. Clin Cancer Res. 2019;25(22):6883-4. doi: 10.1158\/1078-0432.CCR-19-2531.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"key20241121192703_B11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","unstructured":"Liu Y, Wu W, Cai C, Zhang H, Shen H, Han Y. Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther. 2023;8(1):160. doi: 10.1038\/s41392-023-01419-2.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"key20241121192703_B12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/1541-7786.MCR-18-1026","article-title":"Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET\/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers","volume":"17","author":"Schweppe","year":"2019","unstructured":"Schweppe RE, Pozdeyev N, Pike LA, Korch C, Zhou Q, Sams SB, et al. Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET\/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers. Mol Cancer Res. 2019;17(5):1036-48. doi: 10.1158\/1541-7786.MCR-18-1026.","journal-title":"Mol Cancer Res"},{"key":"key20241121192703_B13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fmed.2019.00139","article-title":"Cell Line Derived Xenograft Mouse Models Are a Suitable in vivo Model for Studying Tumor Budding in Colorectal Cancer","volume":"6","author":"Georges","year":"2019","unstructured":"Georges LMC, De Wever O, Galvan JA, Dawson H, Lugli A, Demetter P, et al. Cell Line Derived Xenograft Mouse Models Are a Suitable in vivo Model for Studying Tumor Budding in Colorectal Cancer. Front Med (Lausanne). 2019;6:139. doi: 10.3389\/fmed.2019.00139.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"key20241121192703_B14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159(3):676-90. doi: 10.1016\/j.cell.2014.09.050.","journal-title":"Cell"},{"issue":"3","key":"key20241121192703_B15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126(3):1052-66. doi: 10.1172\/JCI85271.","journal-title":"J Clin Invest"},{"issue":"11","key":"key20241121192703_B16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169653","article-title":"Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics","volume":"133","author":"Lu","year":"2023","unstructured":"Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, et al. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest. 2023;133(11):e169653. doi: 10.1172\/JCI169653.","journal-title":"J Clin Invest"},{"issue":"2","key":"key20241121192703_B17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41574-023-00920-6","article-title":"Genomic alterations in thyroid cancer: biological and clinical insights","volume":"20","author":"Landa","year":"2024","unstructured":"Landa I, Cabanillas ME. Genomic alterations in thyroid cancer: biological and clinical insights. Nat Rev Endocrinol. 2024;20(2):93-110. doi: 10.1038\/s41574-023-00920-6.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"key20241121192703_B18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer","volume":"31","author":"Bible","year":"2021","unstructured":"Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ, Jr., et al. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid. 2021;31(3):337-86. doi: 10.1089\/thy.2020.0944.","journal-title":"Thyroid"},{"issue":"4","key":"key20241121192703_B19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2307\/3869076","article-title":"Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans","volume":"2","author":"Napoli","year":"1990","unstructured":"Napoli C, Lemieux C, Jorgensen R. Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans. Plant Cell. 1990;2(4):279-89. doi: 10.1105\/tpc.2.4.279.","journal-title":"Plant Cell"},{"issue":"6669","key":"key20241121192703_B20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","unstructured":"Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806-11. doi: 10.1038\/35888.","journal-title":"Nature"},{"issue":"4","key":"key20241121192703_B21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","article-title":"RNA interference: biology, mechanism, and applications","volume":"67","author":"Agrawal","year":"2003","unstructured":"Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev. 2003;67(4):657-85. doi: 10.1128\/MMBR.67.4.657-685.2003.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"9","key":"key20241121192703_B22","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1073\/pnas.092143499","article-title":"RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells","volume":"99","author":"Yu","year":"2002","unstructured":"Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A. 2002;99(9):6047-52. doi: 10.1073\/pnas.092143499.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"key20241121192703_B23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2006","article-title":"Strategies for silencing human disease using RNA interference","volume":"8","author":"Kim","year":"2007","unstructured":"Kim DH, Rossi JJ. Strategies for silencing human disease using RNA interference. Nat Rev Genet. 2007;8(3):173-84. doi: 10.1038\/nrg2006.","journal-title":"Nat Rev Genet"},{"issue":"7006","key":"key20241121192703_B24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature02873","article-title":"Mechanisms of gene silencing by double-stranded RNA","volume":"431","author":"Meister","year":"2004","unstructured":"Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431(7006):343-9. doi: 10.1038\/nature02873.","journal-title":"Nature"},{"issue":"4","key":"key20241121192703_B25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cell.2005.08.044","article-title":"Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes","volume":"123","author":"Matranga","year":"2005","unstructured":"Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell. 2005;123(4):607-20. doi: 10.1016\/j.cell.2005.08.044.","journal-title":"Cell"},{"issue":"5","key":"key20241121192703_B26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrg1836","article-title":"High-throughput RNAi screening in cultured cells: a user's guide","volume":"7","author":"Echeverri","year":"2006","unstructured":"Echeverri CJ, Perrimon N. High-throughput RNAi screening in cultured cells: a user's guide. Nat Rev Genet. 2006;7(5):373-84. doi: 10.1038\/nrg1836.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"key20241121192703_B27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s42003-022-03021-8","article-title":"Transfected plasmid DNA is incorporated into the nucleus via nuclear envelope reformation at telophase","volume":"5","author":"Haraguchi","year":"2022","unstructured":"Haraguchi T, Koujin T, Shindo T, Bilir S, Osakada H, Nishimura K, et al. Transfected plasmid DNA is incorporated into the nucleus via nuclear envelope reformation at telophase. Commun Biol. 2022;5(1):78. doi: 10.1038\/s42003-022-03021-8.","journal-title":"Commun Biol"},{"issue":"8","key":"key20241121192703_B28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","unstructured":"Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509-24. doi: 10.1038\/nrm3838.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"key20241121192703_B29","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.celrep.2013.11.020","article-title":"An optimized microRNA backbone for effective single-copy RNAi","volume":"5","author":"Fellmann","year":"2013","unstructured":"Fellmann C, Hoffmann T, Sridhar V, Hopfgartner B, Muhar M, Roth M, et al. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep. 2013;5(6):1704-13. doi: 10.1016\/j.celrep.2013.11.020.","journal-title":"Cell Rep"},{"issue":"4","key":"key20241121192703_B30","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2012.09.042","article-title":"The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo","volume":"151","author":"Gu","year":"2012","unstructured":"Gu S, Jin L, Zhang Y, Huang Y, Zhang F, Valdmanis PN, et al. The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo. Cell. 2012;151(4):900-11. doi: 10.1016\/j.cell.2012.09.042.","journal-title":"Cell"},{"issue":"4","key":"key20241121192703_B31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nbt.3807","article-title":"Prediction of potent shRNAs with a sequential classification algorithm","volume":"35","author":"Pelossof","year":"2017","unstructured":"Pelossof R, Fairchild L, Huang CH, Widmer C, Sreedharan VT, Sinha N, et al. Prediction of potent shRNAs with a sequential classification algorithm. Nat Biotechnol. 2017;35(4):350-3. doi: 10.1038\/nbt.3807.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"key20241121192703_B32","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1111\/febs.16422","article-title":"The intricate balance between microRNA-induced mRNA decay and translational repression","volume":"290","author":"Naeli","year":"2023","unstructured":"Naeli P, Winter T, Hackett AP, Alboushi L, Jafarnejad SM. The intricate balance between microRNA-induced mRNA decay and translational repression. FEBS J. 2023;290(10):2508-24. doi: 10.1111\/febs.16422.","journal-title":"FEBS J"},{"issue":"6808","key":"key20241121192703_B33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35040556","article-title":"Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA","volume":"408","author":"Pasquinelli","year":"2000","unstructured":"Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000;408(6808):86-9. doi: 10.1038\/35040556.","journal-title":"Nature"},{"issue":"D1","key":"key20241121192703_B34","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155-D62. doi: 10.1093\/nar\/gky1141.","journal-title":"Nucleic Acids Res"},{"issue":"24","key":"key20241121192703_B35","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524-9. doi: 10.1073\/pnas.242606799.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"key20241121192703_B36","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","article-title":"Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival","volume":"64","author":"Takamizawa","year":"2004","unstructured":"Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64(11):3753-6. doi: 10.1158\/0008-5472.CAN-04-0637.","journal-title":"Cancer Res"},{"issue":"7043","key":"key20241121192703_B37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834-8. doi: 10.1038\/nature03702.","journal-title":"Nature"},{"issue":"3","key":"key20241121192703_B38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16(3):203-22. doi: 10.1038\/nrd.2016.246.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"key20241121192703_B39","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257-61. doi: 10.1073\/pnas.0510565103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"52","key":"key20241121192703_B40","doi-asserted-by":"crossref","first-page":"19075","DOI":"10.1073\/pnas.0509603102","article-title":"The role of microRNA genes in papillary thyroid carcinoma","volume":"102","author":"He","year":"2005","unstructured":"He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005;102(52):19075-80. doi: 10.1073\/pnas.0509603102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"key20241121192703_B41","doi-asserted-by":"crossref","first-page":"E1401","DOI":"10.1210\/jc.2013-1214","article-title":"In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma","volume":"98","author":"Swierniak","year":"2013","unstructured":"Swierniak M, Wojcicka A, Czetwertynska M, Stachlewska E, Maciag M, Wiechno W, et al. In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma. J Clin Endocrinol Metab. 2013;98(8):E1401-9. doi: 10.1210\/jc.2013-1214.","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"key20241121192703_B42","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/onc.2011.381","article-title":"MicroRNA miR-146b-5p regulates signal transduction of TGF-\u03b2 by repressing SMAD4 in thyroid cancer","volume":"31","author":"Geraldo","year":"2012","unstructured":"Geraldo MV, Yamashita AS, Kimura ET. MicroRNA miR-146b-5p regulates signal transduction of TGF-\u03b2 by repressing SMAD4 in thyroid cancer. Oncogene. 2012;31(15):1910-22. doi: 10.1038\/onc.2011.381.","journal-title":"Oncogene"},{"issue":"27","key":"key20241121192703_B43","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1038\/s41388-019-0804-8","article-title":"Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness","volume":"38","author":"Ramirez-Moya","year":"2019","unstructured":"Ramirez-Moya J, Wert-Lamas L, Riesco-Eizaguirre G, Santisteban P. Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness. Oncogene. 2019;38(27):5486-99. doi: 10.1038\/s41388-019-0804-8.","journal-title":"Oncogene"},{"issue":"24","key":"key20241121192703_B44","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1002\/cncr.28254","article-title":"MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer","volume":"119","author":"Lee","year":"2013","unstructured":"Lee JC, Zhao JT, Clifton-Bligh RJ, Gill A, Gundara JS, Ip JC, et al. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer. 2013;119(24):4358-65. doi: 10.1002\/cncr.28254.","journal-title":"Cancer"},{"issue":"2","key":"key20241121192703_B45","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1210\/jc.2012-2666","article-title":"Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma","volume":"98","author":"Chou","year":"2013","unstructured":"Chou CK, Yang KD, Chou FF, Huang CC, Lan YW, Lee YF, et al. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2013;98(2):E196-205. doi: 10.1210\/jc.2012-2666.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key20241121192703_B46","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1210\/jc.2016-2276","article-title":"IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma","volume":"101","author":"Chou","year":"2016","unstructured":"Chou CK, Chi SY, Huang CH, Chou FF, Huang CC, Liu RT, et al. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2016;101(11):4357-66. doi: 10.1210\/jc.2016-2276.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20241121192703_B47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151968","article-title":"Family of microRNA-146 Regulates RAR\u03b2 in Papillary Thyroid Carcinoma","volume":"11","author":"Czajka","year":"2016","unstructured":"Czajka AA, Wojcicka A, Kubiak A, Kotlarek M, Bakula-Zalewska E, Koperski L, et al. Family of microRNA-146 Regulates RAR\u03b2 in Papillary Thyroid Carcinoma. PLoS One. 2016;11(3):e0151968. doi: 10.1371\/journal.pone.0151968.","journal-title":"PLoS One"},{"key":"key20241121192703_B48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12885-016-2146-z","article-title":"MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells","volume":"16","author":"Lima","year":"2016","unstructured":"Lima CR, Geraldo MV, Fuziwara CS, Kimura ET, Santos MF. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells. BMC Cancer. 2016;16:108. doi: 10.1186\/s12885-016-2146-z.","journal-title":"BMC Cancer"},{"issue":"3","key":"key20241121192703_B49","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3892\/ol.2016.4874","article-title":"p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b","volume":"12","author":"Wang","year":"2016","unstructured":"Wang S, Chen Y, Bai Y. p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b. Oncol Lett. 2016;12(3):2018-22. doi: 10.3892\/ol.2016.4874.","journal-title":"Oncol Lett"},{"issue":"12","key":"key20241121192703_B50","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/gt.2011.100","article-title":"Chemical modification and design of anti-miRNA oligonucleotides","volume":"18","author":"Lennox","year":"2011","unstructured":"Lennox KA, Behlke MA. Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther. 2011;18(12):1111-20. doi: 10.1038\/gt.2011.100.","journal-title":"Gene Ther"},{"issue":"1","key":"key20241121192703_B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-5521(00)00058-2","article-title":"Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA","volume":"8","author":"Braasch","year":"2001","unstructured":"Braasch DA, Corey DR. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol. 2001;8(1):1-7. doi: 10.1016\/s1074-5521(00)00058-2.","journal-title":"Chem Biol"},{"issue":"3","key":"key20241121192703_B52","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: A comprehensive guide for design","volume":"15","author":"Lima","year":"2018","unstructured":"Lima JF, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF. Anti-miRNA oligonucleotides: A comprehensive guide for design. RNA Biol. 2018;15(3):338-52. doi: 10.1080\/15476286.2018.1445959.","journal-title":"RNA Biol"},{"issue":"9","key":"key20241121192703_B53","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nmeth1079","article-title":"MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells","volume":"4","author":"Ebert","year":"2007","unstructured":"Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4(9):721-6. doi: 10.1038\/nmeth1079.","journal-title":"Nat Methods"},{"issue":"1","key":"key20241121192703_B54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029275","article-title":"Rapid generation of microRNA sponges for microRNA inhibition","volume":"7","author":"Kluiver","year":"2012","unstructured":"Kluiver J, Gibcus JH, Hettinga C, Adema A, Richter MK, Halsema N, et al. Rapid generation of microRNA sponges for microRNA inhibition. PLoS One. 2012;7(1):e29275. doi: 10.1371\/journal.pone.0029275.","journal-title":"PLoS One"},{"issue":"D1","key":"key20241121192703_B55","doi-asserted-by":"crossref","first-page":"D308","DOI":"10.1093\/nar\/gkx1107","article-title":"NONCODEV5: a comprehensive annotation database for long non-coding RNAs","volume":"46","author":"Fang","year":"2018","unstructured":"Fang S, Zhang L, Guo J, Niu Y, Wu Y, Li H, et al. NONCODEV5: a comprehensive annotation database for long non-coding RNAs. Nucleic Acids Res. 2018;46(D1):D308-D14. doi: 10.1093\/nar\/gkx1107.","journal-title":"Nucleic Acids Res"},{"issue":"6588","key":"key20241121192703_B56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.abj6987","article-title":"The complete sequence of a human genome","volume":"376","author":"Nurk","year":"2022","unstructured":"Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al. The complete sequence of a human genome. Science. 2022;376(6588):44-53. doi: 10.1126\/science.abj6987.","journal-title":"Science"},{"issue":"6","key":"key20241121192703_B57","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430-47. doi: 10.1038\/s41580-022-00566-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"key20241121192703_B58","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96-118. doi: 10.1038\/s41580-020-00315-9.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7483","key":"key20241121192703_B59","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","article-title":"The multilayered complexity of ceRNA crosstalk and competition","volume":"505","author":"Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344-52. doi: 10.1038\/nature12986.","journal-title":"Nature"},{"issue":"10","key":"key20241121192703_B60","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41419-019-1940-3","article-title":"Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation","volume":"10","author":"Xuan","year":"2019","unstructured":"Xuan Y, Wang Y. Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation. Cell Death Dis. 2019;10(10):694. doi: 10.1038\/s41419-019-1940-3.","journal-title":"Cell Death Dis"},{"issue":"18","key":"key20241121192703_B61","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41388-023-02652-3","article-title":"LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6\/STAT3 signaling","volume":"42","author":"Ma","year":"2023","unstructured":"Ma Y, Zhu Y, Shang L, Qiu Y, Shen N, Wang J, et al. LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6\/STAT3 signaling. Oncogene. 2023;42(18):1419-37. doi: 10.1038\/s41388-023-02652-3.","journal-title":"Oncogene"},{"issue":"2","key":"key20241121192703_B62","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/nar\/gkv1206","article-title":"Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides","volume":"44","author":"Lennox","year":"2016","unstructured":"Lennox KA, Behlke MA. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res. 2016;44(2):863-77. doi: 10.1093\/nar\/gkv1206.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"key20241121192703_B63","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches","volume":"25","author":"Lino","year":"2018","unstructured":"Lino CA, Harper JC, Carney JP, Timlin JA. Delivering CRISPR: a review of the challenges and approaches. Drug Deliv. 2018;25(1):1234-57. doi: 10.1080\/10717544.2018.1474964.","journal-title":"Drug Deliv"},{"issue":"6096","key":"key20241121192703_B64","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816-21. doi: 10.1126\/science.1225829.","journal-title":"Science"},{"issue":"12","key":"key20241121192703_B65","first-page":"827","article-title":"CRISPR pioneers win Nobel prize","volume":"19","author":"Mullard","year":"2020","unstructured":"Mullard A. CRISPR pioneers win Nobel prize. Nat Rev Drug Discov. 2020;19(12):827. doi: 10.1038\/d41573-020-00198-7.","journal-title":"Nat Rev Drug Discov"},{"issue":"6629","key":"key20241121192703_B66","doi-asserted-by":"crossref","first-page":"eadd8643","DOI":"10.1126\/science.add8643","article-title":"CRISPR technology: A decade of genome editing is only the beginning","volume":"379","author":"Wang","year":"2023","unstructured":"Wang JY, Doudna JA. CRISPR technology: A decade of genome editing is only the beginning. Science. 2023;379(6629):eadd8643. doi: 10.1126\/science.add8643.","journal-title":"Science"},{"key":"key20241121192703_B67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas 9 Structures and Mechanisms","volume":"46","author":"Jiang","year":"2017","unstructured":"Jiang F, Doudna JA. CRISPR-Cas9 Structures and Mechanisms. Annu Rev Biophys. 2017;46:505-29. doi: 10.1146\/annurev-biophys-062215-010822.","journal-title":"Annu Rev Biophys"},{"issue":"6121","key":"key20241121192703_B68","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339(6121):819-23. doi: 10.1126\/science.1231143.","journal-title":"Science"},{"issue":"2","key":"key20241121192703_B69","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas 9","volume":"34","author":"Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34(2):184-91. doi: 10.1038\/nbt.3437.","journal-title":"Nat Biotechnol"},{"issue":"W1","key":"key20241121192703_B70","doi-asserted-by":"crossref","first-page":"W171","DOI":"10.1093\/nar\/gkz365","article-title":"CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing","volume":"47","author":"Labun","year":"2019","unstructured":"Labun K, Montague TG, Krause M, Torres Cleuren YN, Tjeldnes H, Valen E. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 2019;47(W1):W171-4. doi: 10.1093\/nar\/gkz365.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"key20241121192703_B71","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas 9 system","volume":"8","author":"Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281-308. doi: 10.1038\/nprot.2013.143.","journal-title":"Nat Protoc"},{"issue":"6","key":"key20241121192703_B72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/crispr.2023.0059","article-title":"The Expanding Dissemination and Distribution Patterns of Diverse CRISPR Plasmids by Addgene","volume":"6","author":"Pyhtila","year":"2023","unstructured":"Pyhtila B, Kasowitz S, Leeson R, Barrangou R. The Expanding Dissemination and Distribution Patterns of Diverse CRISPR Plasmids by Addgene. CRISPR J. 2023;6(6):493-501. doi: 10.1089\/crispr.2023.0059.","journal-title":"CRISPR J"},{"issue":"3","key":"key20241121192703_B73","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/cancers14030844","article-title":"Gene Editing with CRISPR\/Cas Methodology and Thyroid Cancer: Where Are We?","volume":"14","author":"Fuziwara","year":"2022","unstructured":"Fuziwara CS, de Mello DC, Kimura ET. Gene Editing with CRISPR\/Cas Methodology and Thyroid Cancer: Where Are We? Cancers (Basel). 2022;14(3):844. doi: 10.3390\/cancers14030844.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"key20241121192703_B74","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.3390\/ijms24097872","article-title":"Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer","volume":"24","author":"de Mello","year":"2023","unstructured":"de Mello DC, Saito KC, Cristovao MM, Kimura ET, Fuziwara CS. Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer. Int J Mol Sci. 2023;24(9):7872. doi: 10.3390\/ijms24097872.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"key20241121192703_B75","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.advms.2023.10.001","article-title":"CRISPR\/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells","volume":"68","author":"Jin","year":"2023","unstructured":"Jin S, Yong H, Liu Y, Bao W. CRISPR\/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells. Adv Med Sci. 2023;68(2):409-16. doi: 10.1016\/j.advms.2023.10.001.","journal-title":"Adv Med Sci"},{"issue":"8","key":"key20241121192703_B76","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1158\/2159-8290.CD-22-0976","article-title":"Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hurthle Cell Carcinoma","volume":"13","author":"Gopal","year":"2023","unstructured":"Gopal RK, Vantaku VR, Panda A, Reimer B, Rath S, To TL, et al. Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hurthle Cell Carcinoma. Cancer Discov. 2023;13(8):1904-21. doi: 10.1158\/2159-8290.CD-22-0976.","journal-title":"Cancer Discov"},{"issue":"7330","key":"key20241121192703_B77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","unstructured":"Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469(7330):343-9. doi: 10.1038\/nature09784.","journal-title":"Nature"},{"issue":"4","key":"key20241121192703_B78","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1210\/jc.2010-1784","article-title":"Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas","volume":"96","author":"Borbone","year":"2011","unstructured":"Borbone E, Troncone G, Ferraro A, Jasencakova Z, Stojic L, Esposito F, et al. Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. J Clin Endocrinol Metab. 2011;96(4):1029-38. doi: 10.1210\/jc.2010-1784.","journal-title":"J Clin Endocrinol Metab"},{"issue":"23\u201324","key":"key20241121192703_B79","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1080\/15384101.2023.2298027","article-title":"Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma","volume":"22","author":"De Martino","year":"2023","unstructured":"De Martino M, Pellecchia S, Decaussin-Petrucci M, Testa D, Meireles Da Costa N, Pallante P, et al. Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma. Cell Cycle. 2023;22(23-24):2552-65. doi: 10.1080\/15384101.2023.2298027.","journal-title":"Cell Cycle"},{"issue":"5","key":"key20241121192703_B80","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrg3899","article-title":"High-throughput functional genomics using CRISPR-Cas 9","volume":"16","author":"Shalem","year":"2015","unstructured":"Shalem O, Sanjana NE, Zhang F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet. 2015;16(5):299-311. doi: 10.1038\/nrg3899.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"key20241121192703_B81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/15476286.2017.1391443","article-title":"CRISPR\/Cas9-mediated noncoding RNA editing in human cancers","volume":"15","author":"Yang","year":"2018","unstructured":"Yang J, Meng X, Pan J, Jiang N, Zhou C, Wu Z, et al. CRISPR\/Cas9-mediated noncoding RNA editing in human cancers. RNA Biol. 2018;15(1):35-43. doi: 10.1080\/15476286.2017.1391443.","journal-title":"RNA Biol"},{"issue":"2","key":"key20241121192703_B82","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/15476286.2015.1137420","article-title":"D-repeat in the XIST gene is required for X chromosome inactivation","volume":"13","author":"Lv","year":"2016","unstructured":"Lv Q, Yuan L, Song Y, Sui T, Li Z, Lai L. D-repeat in the XIST gene is required for X chromosome inactivation. RNA Biol. 2016;13(2):172-6. doi: 10.1080\/15476286.2015.1137420.","journal-title":"RNA Biol"},{"issue":"1","key":"key20241121192703_B83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/thy.2018.0601","article-title":"Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR\/Cas9n Gene Silencing in Anaplastic Thyroid Cancer","volume":"30","author":"Fuziwara","year":"2020","unstructured":"Fuziwara CS, Saito KC, Kimura ET. Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR\/Cas9n Gene Silencing in Anaplastic Thyroid Cancer. Thyroid. 2020;30(1):81-94. doi: 10.1089\/thy.2018.0601.","journal-title":"Thyroid"},{"issue":"15","key":"key20241121192703_B84","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.3390\/ijms22157992","article-title":"Targeting the Highly Expressed microRNA miR-146b with CRISPR\/Cas9n Gene Editing System in Thyroid Cancer","volume":"22","author":"Santa-Inez","year":"2021","unstructured":"Santa-Inez DC, Fuziwara CS, Saito KC, Kimura ET. Targeting the Highly Expressed microRNA miR-146b with CRISPR\/Cas9n Gene Editing System in Thyroid Cancer. Int J Mol Sci. 2021;22(15):7992. doi: 10.3390\/ijms22157992.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"key20241121192703_B85","article-title":"Challenges of CRISPR\/Cas9 applications for long non-coding RNA genes","volume":"45","author":"Goyal","year":"2017","unstructured":"Goyal A, Myacheva K, Gro\u00df M, Klingenberg M, Duran Arqu\u00e9 B, Diederichs S. Challenges of CRISPR\/Cas9 applications for long non-coding RNA genes. Nucleic Acids Res. 2017;45(3):e12. doi: 10.1093\/nar\/gkw883.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"key20241121192703_B86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008333","article-title":"Xist RNA in action: Past, present, and future","volume":"15","author":"Loda","year":"2019","unstructured":"Loda A, Heard E. Xist RNA in action: Past, present, and future. PLoS Genet. 2019;15(9):e1008333. doi: 10.1371\/journal.pgen.1008333.","journal-title":"PLoS Genet"},{"issue":"2","key":"key20241121192703_B87","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","unstructured":"Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 2013;154(2):442-51. doi: 10.1016\/j.cell.2013.06.044.","journal-title":"Cell"},{"key":"key20241121192703_B88","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1754-1611-9-2","article-title":"Molecular cloning using polymerase chain reaction, an educational guide for cellular engineering","volume":"9","author":"Hoseini","year":"2015","unstructured":"Hoseini SS, Sauer MG. Molecular cloning using polymerase chain reaction, an educational guide for cellular engineering. J Biol Eng. 2015;9:2. doi: 10.1186\/1754-1611-9-2.","journal-title":"J Biol Eng"},{"key":"key20241121192703_B89","author":"Leeson","unstructured":"Leeson R, Tsang J, LaManna C. Plasmids 101 \u2013 Addgene's eBook Collection. Available from: https:\/\/www.addgene.org\/educational-resources\/ebooks\/2023.","journal-title":"Plasmids 101 \u2013 Addgene's eBook Collection"},{"issue":"1\u20132","key":"key20241121192703_B90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(02)01056-9","article-title":"Pushing the limits of the scanning mechanism for initiation of translation","volume":"299","author":"Kozak","year":"2002","unstructured":"Kozak M. Pushing the limits of the scanning mechanism for initiation of translation. Gene. 2002;299(1-2):1-34. doi: 10.1016\/s0378-1119(02)01056-9.","journal-title":"Gene"},{"issue":"D1","key":"key20241121192703_B91","doi-asserted-by":"crossref","first-page":"D892","DOI":"10.1093\/nar\/gkaa1054","article-title":"FANTOM enters 20th year: expansion of transcriptomic atlases and functional annotation of non-coding RNAs","volume":"49","author":"Abugessaisa","year":"2021","unstructured":"Abugessaisa I, Ramilowski JA, Lizio M, Severin J, Hasegawa A, Harshbarger J, et al. FANTOM enters 20th year: expansion of transcriptomic atlases and functional annotation of non-coding RNAs. Nucleic Acids Res. 2021;49(D1):D892-8. doi: 10.1093\/nar\/gkaa1054.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"key20241121192703_B92","first-page":"87","article-title":"Small marker X chromosomes lack the X inactivation center: implications for karyotype\/phenotype correlations","volume":"55","author":"Wolff","year":"1994","unstructured":"Wolff DJ, Brown CJ, Schwartz S, Duncan AM, Surti U, Willard HF. Small marker X chromosomes lack the X inactivation center: implications for karyotype\/phenotype correlations. Am J Hum Genet. 1994;55(1):87-95.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"key20241121192703_B93","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/abio.2001.5010","article-title":"Development of two bacterial artificial chromosome shuttle vectors for a recombination-based cloning and regulated expression of large genes in mammalian cells","volume":"291","author":"Hong","year":"2001","unstructured":"Hong YK, Kim DH, Beletskii A, Lee C, Memili E, Strauss WM. Development of two bacterial artificial chromosome shuttle vectors for a recombination-based cloning and regulated expression of large genes in mammalian cells. Anal Biochem. 2001;291(1):142-8. doi: 10.1006\/abio.2001.5010.","journal-title":"Anal Biochem"},{"issue":"6","key":"key20241121192703_B94","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3390\/cancers14061588","article-title":"Clinical Applications of Short Non-Coding RNA- Based Therapies in the Era of Precision Medicine","volume":"14","author":"Smith","year":"2022","unstructured":"Smith ES, Whitty E, Yoo B, Moore A, Sempere LF, Medarova Z. Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine. Cancers (Basel). 2022;14(6):1588. doi: 10.3390\/cancers14061588.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"key20241121192703_B95","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","unstructured":"Kim T, Croce CM. MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Exp Mol Med. 2023;55(7):1314-21. doi: 10.1038\/s12276-023-01050-9.","journal-title":"Exp Mol Med"},{"issue":"18","key":"key20241121192703_B96","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","unstructured":"Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368(18):1685-94. doi: 10.1056\/NEJMoa1209026.","journal-title":"N Engl J Med"},{"issue":"7897","key":"key20241121192703_B97","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells","volume":"602","author":"Melenhorst","year":"2022","unstructured":"Melenhorst JJ, Chen GM, Wang M, Porter DL, Chen C, Collins MA, et al. Decade-long leukaemia remissions with persistence of CD4(+) CAR T cells. Nature. 2022;602(7897):503-9. doi: 10.1038\/s41586-021-04390-6.","journal-title":"Nature"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T19:27:30Z","timestamp":1732217250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/modulating-gene-expression-as-a-strategy-to-investigate-thyroid-cancer-biology\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":97,"journal-issue":{"issue":"special issue","published-print":{"date-parts":[[2024,11,18]]}},"alternative-id":["10.20945\/2359-4292-2024-0073"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2024-0073","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e240073"}}